Glucovance is a combination of two medications – glyburide and metformin – which are used to treat type 2 diabetes. It is designed to help patients better manage their blood sugar levels and reduce the need for additional medications. It works by increasing the body’s sensitivity to insulin, which helps to reduce blood sugar levels.
Uses: Glucovance is used to treat type 2 diabetes in adults and children over the age of 10. It is usually prescribed when diet and exercise alone are not enough to control blood sugar levels. It can also be used in combination with other diabetes medications.
Disadvantages: Glucovance can cause side effects such as nausea, vomiting, stomach pain, headache, and diarrhea. It can also cause low blood sugar, which can lead to dizziness, confusion, and sweating. In rare cases, Glucovance can cause lactic acidosis, a life-threatening condition.
History of Discovery: Glucovance was first approved by the U.S. Food and Drug Administration (FDA) in 1995. It was developed by Bristol-Myers Squibb, a pharmaceutical company based in the United States. The medication was developed as a combination of glyburide and metformin to help people with type 2 diabetes better manage their blood sugar levels.
Active Ingredients and Synonyms: Glucovance contains two active ingredients – glyburide and metformin. Glyburide is also known as glibenclamide, and metformin is also known as Glucophage. Both medications are used to help control blood sugar levels in people with type 2 diabetes.